IP Verse

Novel Tnf Structure For Use In Therapy

Patent No. EP3311168 (titled "Novel Tnf Structure For Use In Therapy") was filed by UCB Biopharma on Oct 22, 2015. The application was issued on May 10, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR H ULRICH DORRIESFeb 12, 2024DORRIES
DR H ULRICH DORRIESFeb 12, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3311168

UCB BIOPHARMA
Application Number
EP15784067A
Filing Date
Oct 22, 2015
Status
Granted And Under Opposition
Apr 7, 2023
Publication Date
May 10, 2023
External Links
Slate, Register , Google Patents